Earth Science Tech (ETST) Raw Materials (2024 - 2025)
Earth Science Tech's (ETST) quarterly Raw Materials came in at $783374.0 in Q4 2025, up 646.35% on a YoY basis from $104961.0 in Q4 2024, and down 5.09% quarter-over-quarter from $825414.0 in Q3 2025.
Powered by 
Analysis
Earth Science Tech (ETST) Raw Materials (2024 - 2025) Analysis & Trends
Earth Science Tech (ETST) has reported Raw Materials for 2 consecutive years, with $783374.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Raw Materials rose 646.35% year-over-year to $783374.0; the trailing twelve-month figure through Dec 2025 stood at $783374.0 (up 646.35% YoY), and the FY2025 full-year result was $411810.0, up 54.37% from the prior year.
- Raw Materials fell to $783374.0 in Q4 2025 per ETST's latest filing, from $825414.0 in the prior quarter.
- Across five years, Raw Materials topped out at $825414.0 in Q3 2025 and bottomed at $104961.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 783,374.00 |
| Sep 30, 2025 | 825,414.00 |
| Jun 30, 2025 | 549,487.00 |
| Mar 31, 2025 | 411,810.00 |
| Dec 31, 2024 | 104,961.00 |
| Sep 30, 2024 | 334,312.00 |
| Jun 30, 2024 | 193,731.00 |
| Mar 31, 2024 | 266,776.00 |